These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29045524)

  • 21. Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis.
    Fuentes R; Osorio D; Expósito Hernandez J; Simancas-Racines D; Martinez-Zapata MJ; Bonfill Cosp X
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012086. PubMed ID: 30125049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 1: Principles of Combined Treatment.
    Zhang I; Formenti SC; Knisely JPS
    Oncology (Williston Park); 2018 Feb; 32(2):e28-e32. PubMed ID: 29492951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of Combined PD-1 Pathway Inhibition and Intracranial Radiation Therapy in Non-Small Cell Lung Cancer.
    Hubbeling HG; Schapira EF; Horick NK; Goodwin KEH; Lin JJ; Oh KS; Shaw AT; Mehan WA; Shih HA; Gainor JF
    J Thorac Oncol; 2018 Apr; 13(4):550-558. PubMed ID: 29378267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases.
    Kowalski ES; Remick JS; Sun K; Alexander GS; Khairnar R; Morse E; Cherng HR; Berg LJ; Poirier Y; Lamichhane N; Becker S; Chen S; Molitoris JK; Kwok Y; Regine WF; Mishra MV
    Radiat Oncol; 2020 Oct; 15(1):245. PubMed ID: 33109224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
    Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ
    Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI characteristics in treatment for cerebral melanoma metastasis using stereotactic radiosurgery and concomitant checkpoint inhibitors or targeted therapeutics.
    Rauch M; Tausch D; Stera S; Blanck O; Wolff R; Meissner M; Urban H; Hattingen E
    J Neurooncol; 2021 May; 153(1):79-87. PubMed ID: 33761055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiosurgery/stereotactic radiotherapy in combination with immunotherapy and targeted agents for melanoma brain metastases.
    Trino E; Mantovani C; Badellino S; Ricardi U; Filippi AR
    Expert Rev Anticancer Ther; 2017 Apr; 17(4):347-356. PubMed ID: 28277101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Brain Metastases in the New Era of Checkpoint Inhibition.
    Lauko A; Thapa B; Venur VA; Ahluwalia MS
    Curr Neurol Neurosci Rep; 2018 Aug; 18(10):70. PubMed ID: 30121715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data.
    Lehrer EJ; Peterson J; Brown PD; Sheehan JP; Quiñones-Hinojosa A; Zaorsky NG; Trifiletti DM
    Radiother Oncol; 2019 Jan; 130():104-112. PubMed ID: 30241791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current multidisciplinary management of brain metastases.
    Moravan MJ; Fecci PE; Anders CK; Clarke JM; Salama AKS; Adamson JD; Floyd SR; Torok JA; Salama JK; Sampson JH; Sperduto PW; Kirkpatrick JP
    Cancer; 2020 Apr; 126(7):1390-1406. PubMed ID: 31971613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma.
    Stera S; Balermpas P; Blanck O; Wolff R; Wurster S; Baumann R; Szücs M; Loutfi-Krauss B; Wilhelm ML; Seifert V; Rades D; Rödel C; Dunst J; Hildebrandt G; Arnold A; Meissner M; Kähler KC
    Melanoma Res; 2019 Apr; 29(2):187-195. PubMed ID: 30802230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases.
    Hilbers ML; Dimitriou F; Lau P; Bhave P; McArthur GA; Zimmer L; Kudura K; Gérard CL; Levesque MP; Michielin O; Dummer R; Cheng PF; Mangana J
    Eur J Cancer; 2021 Oct; 156():149-163. PubMed ID: 34454317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
    Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M
    Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined Immunotherapy and Stereotactic Radiotherapy Improves Neurologic Outcomes in Patients with Non-small-cell Lung Cancer Brain Metastases.
    Enright TL; Witt JS; Burr AR; Yadav P; Leal T; Baschnagel AM
    Clin Lung Cancer; 2021 Mar; 22(2):110-119. PubMed ID: 33281062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic radiosurgery with and without checkpoint inhibition for patients with metastatic non-small cell lung cancer to the brain: a matched cohort study.
    Shepard MJ; Xu Z; Donahue J; Eluvathingal Muttikkal TJ; Cordeiro D; Hansen L; Mohammed N; Gentzler RD; Larner J; Fadul CE; Sheehan JP
    J Neurosurg; 2019 Jul; 133(3):685-692. PubMed ID: 31349225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stereotactic radiotherapy of brain metastases in complex situations].
    Noel G; Keller A; Antoni D
    Cancer Radiother; 2019 Oct; 23(6-7):708-715. PubMed ID: 31477442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
    Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
    J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors.
    Lee JH; Chen HY; Hsu FM; Chen JS; Liao WY; Shih JY; Yu CJ; Chen KY; Tsai TH; Yang JC
    Oncologist; 2019 Dec; 24(12):e1417-e1425. PubMed ID: 31127020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe Radiation Necrosis Refractory to Surgical Resection in Patients with Melanoma and Brain Metastases Managed with Ipilimumab/Nivolumab and Brain-Directed Stereotactic Radiation Therapy.
    Shi DD; Arnaout O; Bi WL; Buchbinder EI; Cagney DN; Insco ML; Liu D; Schoenfeld JD; Aizer AA
    World Neurosurg; 2020 Jul; 139():226-231. PubMed ID: 32330622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?
    Colaco RJ; Martin P; Kluger HM; Yu JB; Chiang VL
    J Neurosurg; 2016 Jul; 125(1):17-23. PubMed ID: 26544782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.